Condition

Diabetic Macular Oedema

ClinicalTrials.gov condition label

Clinical trials6

Recruiting0

Common interventions7

Lead sponsors shown4

Clinical trials

6 shown

Near Infrared Photobiomodulation Treatment for Diabetic Macular OedemaNCT02181400 · 2016-04-19

Noctura400 Treatment for Diabetic Retinopathy (CANDLE)NCT02207712 · 2014-11-01

Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular OedemaNCT01787669 · 2013-06-01

To Evaluate the Comparative Efficacy of Lucentis (Ranibizumab) 0.5mg Intravitreal Injection in Patients With Diabetic Macular Oedema (DME) With Well Controlled and Poorly Controlled Diabetes MellitusNCT03495765 · 2011-03-01

Clinical Study of the Effect of Intravenous Galactose on Diabetic Macular OedemaNCT00427986 · 2007-01-01

Quantification of Rising the Osmotic Pressure in Diabetic Intraretinal Fluid Accumulation (Diabetic Macular Oedema)NCT00333671 · 2004-12-01

Common interventions

RanibizumabDRUG2 Avastin (Bevacizumab)DRUG1 Ellex Integre NIR laserDEVICE1 Galactose, intravenousDRUG1 GlycerolDRUG1 Noctura 400 Eye MaskDEVICE1 Ozurdex (dexamethasone)DRUG1

Leading sponsors

Glostrup University Hospital, Copenhagen2 University of Sydney2 Marsden Eye Specialists1 PolyPhotonix Medical1

Trial status mix

COMPLETED4

TERMINATED2

Phase mix

NA4

PHASE21

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.